Effects of Chamomile With L-theanine Beverage Among Young Women Experiencing Primary Dysmenorrhea
NCT ID: NCT07092878
Last Updated: 2025-07-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
30 participants
INTERVENTIONAL
2025-03-01
2025-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Daily Ginger Tea Consumption in Reducing Discomfort During Menstruation
NCT03300999
The Effectiveness of Chinese Medicine Nuan-gong-ye on Primary Dysmenorrhea
NCT06295822
Effect of Lavender Inhalation on Dysmenorrhea
NCT05995730
Chinese Herbal Medicine for Gynecologic Patients
NCT06187376
Danshen-Jiang-Fu Granule Prepared by Danshen From Different Producing Areas for Primary Dysmenorrhea
NCT02602522
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CTT
Participants in the intervention group will consume a chamomile with L-theanine (CTT) beverage, which contains 480 mg of chamomile extract and 200 mg of L-theanine.
Chamomile (Matricaria recutita)
Participants in the intervention group will consume the chamomile with L-theanine (CTT) beverage, which contains 480 mg of chamomile extract and 200 mg of L-theanine.
Non-CTT
Participants in the control group will consume a chamomile-flavored beverage (non-CTT), which is flavored with commercial chamomile flavoring.
Chamomile
A chamomile-flavored beverage
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Chamomile (Matricaria recutita)
Participants in the intervention group will consume the chamomile with L-theanine (CTT) beverage, which contains 480 mg of chamomile extract and 200 mg of L-theanine.
Chamomile
A chamomile-flavored beverage
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Regular monthly menstruation
* No history of allergies or psychological/gynecological illnesses
* Absence of secondary dysmenorrhea
* No current use of any medications
* No ongoing non-pharmacological management for dysmenorrhea.
Exclusion Criteria
* Breastfeeding
18 Years
30 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universiti Tunku Abdul Rahman
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tan Chin Xuan
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UTAR
Kampar, Perak, Malaysia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
78-373
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.